Related Experiment Video
Updated: Jul 28, 2026
08:01
Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Apathy in Alzheimer's disease
A M Landes1, S D Sperry, M E Strauss
1Kent State University, Kent, Ohio, USA.
Journal of the American Geriatrics Society
|February 15, 2002
Summary
Apathy, a common Alzheimer's disease (AD) symptom, impairs daily function and caregiver well-being. Early recognition and distinct diagnosis from depression are crucial for effective treatment and improved patient outcomes.
Area of Science:
- Neuroscience
- Geriatric Medicine
- Behavioral Neurology
Background:
- Apathy is the most frequent behavioral change in Alzheimer's disease (AD), often underrecognized.
- It signifies executive cognitive dysfunction, impacting daily activities and increasing caregiver burden.
- Apathy is linked to frontal subcortical network pathology in AD.
Purpose of the Study:
- To highlight the significance of apathy in Alzheimer's disease.
- To emphasize the need for accurate assessment and differentiation from depression.
- To underscore the implications for patient care and caregiver support.
Main Methods:
- Review of existing literature on apathy in AD.
- Analysis of neuroanatomical and neuropsychological correlates.
- Comparison of assessment challenges and diagnostic criteria.
Main Results:
- Apathy leads to decreased daily function and increased reliance on caregivers.
- Neuroanatomical correlates implicate frontal subcortical networks.
- Distinguishing apathy from depression is critical due to different treatment approaches.
Conclusions:
- Accurate assessment of apathy in AD is essential for appropriate management.
- Further research is needed to clarify its neurobiological underpinnings.
- Improved diagnosis and treatment of apathy can enhance patient functioning and reduce caregiver stress.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...